Explore the most recent editions of MPO Magazine, featuring expert commentary, industry trends, and breakthrough technologies.
Access the full digital version of MPO Magazine anytime, anywhere, with interactive content and enhanced features.
Join our community of medical device professionals. Subscribe to MPO Magazine for the latest news and updates delivered straight to your mailbox.
Explore the transformative impact of additive manufacturing on medical devices, including design flexibility and materials.
Learn about outsourcing options in the medical device sector, focusing on quality, compliance, and operational excellence.
Stay updated on the latest electronic components and technologies driving innovation in medical devices.
Discover precision machining and laser processing solutions that enhance the quality and performance of medical devices.
Explore the latest materials and their applications in medical devices, focusing on performance, biocompatibility, and regulatory compliance.
Learn about advanced molding techniques for producing high-quality, complex medical device components.
Stay informed on best practices for packaging and sterilization methods that ensure product safety and compliance.
Explore the latest trends in research and development, as well as design innovations that drive the medical device industry forward.
Discover the role of software and IT solutions in enhancing the design, functionality, and security of medical devices.
Learn about the essential testing methods and standards that ensure the safety and effectiveness of medical devices.
Stay updated on innovations in tubing and extrusion processes for medical applications, focusing on precision and reliability.
Stay ahead with real-time updates on critical news affecting the medical device industry.
Access unique content and insights not available in the print edition of the MPO Magazine.
Explore feature articles that delve into specific topics within the medical device industry, providing in-depth analysis and insights.
Gain perspective from industry experts through regular columns addressing key challenges and innovations in medical devices.
Read the editor’s thoughts on the current state of the medical device industry.
Discover the leading companies in the medical device sector, showcasing their innovations and contributions to the industry.
Explore detailed profiles of medical device contract manufacturing and service provider companies, highlighting their capabilities and offerings.
Learn about the capabilities of medical device contract manufacturing and service provider companies, showcasing their expertise and resources.
Watch informative videos featuring industry leaders discussing trends, technologies, and insights in medical devices.
Short, engaging videos providing quick insights and updates on key topics within the medical device industry.
Tune in to discussions with industry experts sharing their insights on trends, challenges, and innovations in the medical device sector.
Participate in informative webinars led by industry experts, covering various topics relevant to the medical device sector.
Stay informed on the latest press releases and announcements from leading companies in the medical device manufacturing industry.
Access comprehensive eBooks covering a range of topics on medical device manufacturing, design, and innovation.
Highlighting the innovators and entrepreneurs who are shaping the future of medical technology.
Explore sponsored articles and insights from leading companies in the medical device manufacturing sector.
Read in-depth whitepapers that explore key issues, trends, and research findings for the medical device industry.
Discover major industry events, trade shows, and conferences focused on medical devices and technology.
Get real-time updates and insights live from the CompaMed/Medica conference floor.
Join discussions and networking opportunities at the MPO Medtech Forum, focusing on the latest trends and challenges in the industry.
Attend the MPO Summit for insights and strategies from industry leaders shaping the future of medical devices.
Participate in the ODT Forum, focusing on orthopedic device trends and innovations.
Discover advertising opportunities with MPO to reach a targeted audience of medical device professionals.
Review our editorial guidelines for submissions and contributions to MPO.
Read about our commitment to protecting your privacy and personal information.
Familiarize yourself with the terms and conditions governing the use of MPOmag.com.
What are you searching for?
Holmes founded Theranos in 2003, envisioning a way to diagnose more than 100 diseases and conditions—from cancer to cholesterol—from a single drop of blood.
October 1, 2021
By: Michael Barbella
Managing Editor
The wait is over. Three years after her very public fall from grace, Elizabeth Holmes is finally getting the chance to tell her story. The truth, or so she claims (her version of it, anyway). Few are unfamiliar with Holmes’ saga: The tale of the Steve Jobs wannabe who dropped out of Stanford University at 19 to start a company offering “revolutionary” blood testing technology has been chronicled at length in newspapers, magazines, books, podcasts, and film, with Hollywood casting both Amanda Seyfried and Academy Award-winner Jennifer Lawrence as the baritone-voiced business executive. Holmes, as the story goes, founded her company Theranos in 2003, envisioning a way to diagnose more than 100 diseases and conditions—from cancer to cholesterol—from a single drop of blood. Though she lacked formal medical training and a college degree, Holmes convinced scientists, former government bigwigs, and wealthy investors to support her innovation; the Theranos board included Henry Kissinger, George Schultz, and James Mattis, while backers like Rupert Murdoch and the Walton family (Walmart) helped boost the company’s valuation to $10 billion by 2015. Attracting such high-level support was relatively easy for Holmes, as she exploited the benefits of good timing and gender inequity to build her fairy tale-like empire. She fit the mold of the young, genius startup founder who could do no wrong. “She was going to be the first woman who reached billionaire status and join the pantheon of tech leaders,” Pulitzer Prize-winning journalist John Carreyrou told The Guardian (Britain) in late August. “People were really rooting for her—young girls were writing her letters. A lot of people wanted to believe this fairytale, because it would have represented real progress in this very male-dominated world of Silicon Valley. Unfortunately, it was a fairy tale that wasn’t true.” Carreyrou, in fact, was instrumental in unraveling that fable. His investigative report in The Wall Street Journal exposed the truth behind the Theranos mythos—that its secretive, “revolutionary” technology was highly inaccurate and didn’t work, that its equipment failed quality control measures, and that management deliberately worked to conceal its failures. That was the beginning of the end for Theranos and Holmes. In 2018, Theranos collapsed, leaving the former Silicon Valley darling to face a very unhappily-ever-after future of hefty fines, a 10-year ban in corporate management, and a dozen federal fraud charges that carry a maximum 20-year prison term. Holmes, not surprisingly, has denied any wrongdoing in her company’s epic rise and fall. She’s pleaded not guilty to the fraud charges, a decision that practically guarantees her the opportunity to share her side of the Theranos story. Savvy move on Holmes’ part, given the nature of her story. In court filings submitted ahead of her federal trial in San Jose, Calif., Holmes’ legal team claims she was a victim of abuse by her business partner and former boyfriend, Ramesh “Sunny” Balwani. Theranos’ former chief operating officer, Balwani faces identical fraud charges but will be tried separately from Holmes early next year. Like Holmes, he has pleaded not guilty. The court documents accuse Balwani of a “pattern of abuse and coercive control,” and TIME magazine reported that Holmes claims she experiences “debilitating PTSD symptoms” simply by being near him. “Out of hundreds of securities fraud cases, I have never seen this defense,” John C. Coffee Jr., a Columbia Law School professor and expert on Silicon Valley fraud cases, told TIME. “There is a timing problem in her story. She was an extraordinary success on her own without Sunny.” Nevertheless, Holmes’ legal team claims Balwani controlled her every move and psychologically manipulated her throughout their decade-long relationship (the pair met when Holmes was 18 and Balwani was 37). Holmes contends Balwani dictated her meals, fashion, personal spending, hours of sleep, and social engagements; he also allegedly monitored her phone calls, texts, and emails. Moreover, Holmes claims Balwani verbally disparaged her and physically abused her, reportedly throwing “hard, sharp objects” at her, TIME reports. Balwani’s attorneys have denied Holmes’ abuse accusations, calling the allegations “deeply offensive, devastating personally to him, and highly and unfairly prejudicial to his defense” in court filings. The federal government, however, isn’t buying Holmes’ story. On the first day of her federal trial last month, Assistant U.S. Attorney Robert Leach painted Holmes as a liar and misled investors to deliberately keep her sham company afloat. “Out of time, out of money, Elizabeth Holmes decided to lie,” Leach said. “This is a case about fraud, about lying and cheating to get money. She owned it, she controlled it, the buck stopped with her,” Leach said. Did it really stop there? Not in Holmes’ version of the story. Regardless of where the buck ultimately stopped, Holmes’ attorneys claim she is guilty of nothing more than honest mistakes. “Mistakes are not crimes,” said Lance Wade, one of Holmes’ attorneys. “A failed business does not make a CEO a criminal. Ms. Holmes did not go to work every day intending to lie, cheat and steal… failure is not a crime. Trying your hardest and coming up short is not a crime.” Depends on the story. And the storyteller.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !